You are here: Industry Insights > Biopharmaceutical

News List

Espero Pharma and Armetheon Merge contractpharma
April 25, 2017
Creates a premier cardiovascular focused biopharmaceutical company
Novartis obtains rights to use Parvus’ Navacim to develop products for T1D pharmaceutical-technology
April 24, 2017
Biopharmaceutical company Parvus Therapeutics has entered a licence and collaboration agreement with Novartis for its lead, Navacim, to treat type 1 diabetes (T1D).
Median Technologies partners with inVentiv Health biospectrumasia
April 11, 2017
Median, a leading services provider for image interpretation and management in oncology trials, will complement inVentiv Health's comprehensive oncology solutions.
Paratek Pharmaceuticals Opens New Office in King of Prussia, PA americanpharmaceuticalreview
March 27, 2017
Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, has opened its expanded office in King of Prussia, Pennsylvania.
ViraCyte Receives Orphan Drug Designation for Viralym-C firstwordpharma
January 25, 2017
ViraCyte, LLC announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to Viralym-C, a ready to administer T cell immunotherapy product for the treatment of cytomegalovirus (CMV) in severely immunocompromised pa
Sartorius Supports Mainstream Adoption of QbD contractpharma
January 25, 2017
Develops technology platform to meet the requirements of today’s upstream bioprocessing
Kymab appoints Dr Arndt Schottelius as Executive Vice President Research & Development firstwordpharma
January 24, 2017
Kymab Group Limited announced today the appointment of Dr Arndt Schottelius as its first Executive Vice President Research & Development.

Previous page 1 2 3 4 5 6 7 Next page